Sunesis Pharmaceuticals Inc (NASDAQ: SNSS) and Hamilton Thorne Ltd (TSXV: HTL), lead the top small cap stock gainers for various sectors on both sides of the border, including one that saw its share price surge 94%.
Top U.S. Gainer
|
Company Name |
Exchange |
Ticker |
Market Cap |
Last Price |
Last Volume |
Price Return |
Price Return |
52-Week High |
52-Week Low |
|
Sunesis Pharmaceuticals Inc |
NASDAQ |
SNSS |
143.1 |
2.31 |
16,256,690 |
38.3% |
35.9% |
8.46 |
1.00 |
Sunesis Pharmaceuticals Inc (NASDAQ: SNSS), engaged in the development and commercialization of oncology therapeutics for the treatment of solid and hematologic cancers, was the top performer in the U.S. healthcare sector after climbing 38.3% and closed at $2.31 Monday, while recording significant trading volumes of 16.2 million shares. The company recently announced that results from its phase 3 VALOR trials of vosaroxin and cytarabine in patients with relapsed or refractory acute myeloid leukemia (AML) will be presented in a late breaking oral presentation at the 56th American Society of Hematology annual meeting, taking place December from 6-9 in San Francisco, California. During the past 5-trading sessions, SNSS gained 35.9% with daily average trading volumes of 3.6 million shares, while the stock accumulated 60.4% gain during the past one month with daily average trading volumes of 2.5 million shares.
1-Year Price Chart
Top Canadian Gainer
|
Company Name |
Exchange |
Ticker |
Market Cap |
Last Price |
Last Volume |
Price Return |
Price Return |
52-Week High |
52-Week Low |
|
Hamilton Thorne Ltd |
TSXV |
HTL |
16.1 |
0.31 |
1,387,040 |
93.7% |
100.0% |
0.35 |
0.04 |
Hamilton Thorne Ltd (TSXV: HTL), engaged in providing laser systems and instruments for in-vitro cell applications in the regenerative medicine research and fertility clinic markets was the top sector gainer after skyrocketing 93.7% and closed at C$0.31 Monday, while recording significant trading volumes of 1.3 million shares. The company recently announced the initial closing of its over-subscribed C$750,000 private placement, where the fund will be directed to accelerate product development and to support future growth of the company. During the past 5-trading sessions, HTL gained 100.0% with daily average trading volumes of 378,103 shares, while the stock accumulated 138.5% gain during the past one month with daily average trading volumes of 110,729 shares. The stock is up 520.0% year-to-date.
1-Year Price Chart
